Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)
The summary for the Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional): The purpose of this Funding Opportunity Announcement (FOA) is to transition the core resources and biomedical research activities of Centers of Biomedical Research Excellence (COBRE) into independence and sustainability.
Federal Grant Title: | Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-20-115 |
Type of Funding: | Grant |
CFDA Numbers: | 93.859 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | May 27th, 2022 |
Original Application Deadline: | May 27th, 2022 |
Posted Date: | February 20th, 2020 |
Creation Date: | February 20th, 2020 |
Archive Date: | July 2nd, 2022 |
Total Program Funding: | |
Maximum Federal Grant Award: | $750,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | February 20th, 2020 |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See FOA for full eligibility details.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PAR-20-115.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Medical Scientist Training Program (MSTP) (T32)
- • Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)
- • Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial ...
- • Modules for Enhancing Biomedical Research Workforce Training (R25 - Independent Clinical T...
- • Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32)
- • Tools for Genetic and Genomic Studies in Emerging Model Organisms
- • Evolution of Infectious Diseases
- • Mbrs Support of Continuous Research Excellence (Score)
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)